General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Bayer(SIGNIFICANT), Boehringer-Ingelhiem(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Medtronic(SIGNIFICANT), Edwards(SIGNIFICANT), Abbott Laboratories(SIGNIFICANT), Amarin(SIGNIFICANT), AstraZeneca(SIGNIFICANT), Alnylam(NONE), ReCor Medical(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: JNJ(SIGNIFICANT)

View Full Disclosure